Back to Search Start Over

Venetoclax plus bortezomib and dexamethasone in heavily pretreated end-stage myeloma patients without t(11;14): A real-world cohort.

Authors :
Jelinek, Tomas
Popkova, Tereza
Duras, Juraj
Mihalyova, Jana
Kascak, Michal
Benkova, Katerina
Plonkova, Hana
Cerna, Lucie
Koristek, Zdenek
Simicek, Michal
Hajek, Roman
Source :
Hematological Oncology; Aug2020, Vol. 38 Issue 3, p412-414, 3p
Publication Year :
2020

Subjects

Subjects :
TUMOR lysis syndrome
DEXAMETHASONE

Details

Language :
English
ISSN :
02780232
Volume :
38
Issue :
3
Database :
Complementary Index
Journal :
Hematological Oncology
Publication Type :
Academic Journal
Accession number :
145206042
Full Text :
https://doi.org/10.1002/hon.2736